Karima Addetia
Cardiovascular Disease · Chicago, ILNPI 1740612993
Payments from drug & device makers
What this record shows
This record is dominated by gifts: $34,247 of the $37,132 with a category attached, or 92.2%. Philips North America LLC accounts for 92.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $25,561 and has fallen 95.2% since, to $1,231 in 2025. Among cardiovascular disease clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $350.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$34K
- Edwards Lifesciences$1K
- AstraZeneca$428
- Johnson & Johnson$382
- Novartis$203
- Lantheus Medical Imaging, Inc.$169
- plus $574 from 9 others
Across 1 payment — averaging $75,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$75K
What the payments were for
- Travel & lodging$9152%
- Food & beverage$1,9705%
- Gifts$34,24792%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 3 | $34,262 |
| Edwards Lifesciences | 6 | $1,113 |
| AstraZeneca | 28 | $428 |
| Johnson & Johnson | 24 | $382 |
| Novartis | 10 | $203 |
| Lantheus Medical Imaging, Inc. | 10 | $169 |
| Abbott | 5 | $127 |
| Pfizer | 5 | $123 |
| Heartflow, Inc. | 3 | $116 |
| Amgen | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Boston Scientific | 1 | $30 |
| Medtronic | 1 | $17 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOMTEC license$34,247
- EVOQUE$494
How this compares
$37,132 in reported general payments places this provider in the 90th percentile of 932 cardiovascular disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 15 | $339 |
| Carvedilol | 16 | $235 |
| Hydralazine Hcl | 20 | $228 |
| Atorvastatin Calcium | 16 | $185 |
| Torsemide | 11 | $136 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.